Global Asthma Management Products Market Professional Survey Report 2019

Asthma is a chronic disease, which cannot be cured only appropriate management is possible to control the disease. Asthma targets airways of the lungs causing it to inflame, swallow and tightens the airway of the lungs, causing respiratory tract infection and causing symptoms such as coughing, shortness of breath, tightness, and wheezing. The symptoms of the asthma are related to physical activity, even healthy people suffer from asthma symptoms during vigorous exercise. This type of asthma is called exercise-induced bronchoconstriction (EIB).  This type of asthma is controlled and the symptoms are kept under control by developing a management plan by a physician. People with family history of asthma are more prone to this illness and develop allergies frequently. This type of asthma is called allergic asthma. The allergies/asthma due to toxic fumes, gases, dust during the occupation/work in known as occupational asthma. Childhood asthma effects millions of children and is developed in mainly during first five years of life.
Asthma is diagnosed by looking after patient medical history and performing breathing tests, this test helps to measure the amount of air the lungs can hold and examines asthma severity. The medication to manage asthma symptoms are taken daily and contains inhaled corticosteroids such as ciclesonide, budesonide, flunisolide and others. Short acting beta agonist are prescribed for quick relief.  The inhaler contains beta blockers and inhaled corticosteroid. Leukotriene modifiers are prescribed for asthma as oral medication. The people suffering from symptoms suffer from respiratory infections such as influenza and pneumonia.
Increasing incidence of respiratory diseases, demand for cost effective medication, as the cost for asthma medication is very high in U.S market. New drug development and approvals, uptake of novel biologic agents, strong brand loyalty, no replacement of inhaler devices, the rise in geriatric population, rise in initiatives implemented by the government and other non-government organizations.

The global Asthma Management Products market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Asthma Management Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Asthma Management Products market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Asthma Management Products in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Asthma Management Products manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GE Healthcare
Merck
Baxter
GlaxoSmithKline
Sanofi-Aventis
Novartis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Corticosteroids
Bronchodilators
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Online Pharmacy

Frequently Asked Questions